Clapés, Victoria
34  Ergebnisse:
Personensuche X
?
3

Real-World Evidence of Daratumumab Monotherapy in Relapsed/..:

Moreno, David F. ; Clapés, Victoria ; Soler, Juan Alfons...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  8 - p. 635-642 , 2022
 
?
4

Dose intensity and treatment duration of bortezomib in tran..:

Ibarra, Gladys ; Peña, Marta ; Abril, Laura...
European Journal of Haematology.  107 (2021)  2 - p. 246-254 , 2021
 
?
6

Response to First Cycle Is the Major Predictor of Long-Term..:

Gassiot, Susanna ; González, Yolanda ; Morgades, Mireia...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  9 - p. 585-592.e1 , 2019
 
?
8

Feasibility and efficacy of outpatient therapy with interme..:

Vives, Susana ; Oriol, Albert ; Piernas, Sònia...
European Journal of Haematology.  95 (2015)  6 - p. 576-582 , 2015
 
?
9

Neurological monitoring reduces the incidence of bortezomib..:

Velasco, Roser ; Petit, Josep ; Clapés, Victoria...
Journal of the Peripheral Nervous System.  15 (2010)  1 - p. 17-25 , 2010
 
?
10

New factors involved in the appearance of Mandibular Osteon..:

Magán, Alicia Senín ; Abella, Eugenia ; Blade, Joan...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e193 , 2019
 
?
11

Genetic variants of CTLA4 are associated with clinical outc..:

Gonzalez Montes, Yolanda ; Rodriguez Romanos, Rocío ; Villavicencio, Alicia...
Reproducció del document publicat a: https://doi.org/10.3389/fimmu.2023.1158105.  , 2023
 
?
12

The direct and indirect effects of COVID‐19 pandemic in a r..:

Condom, Maria ; Mussetti, Alberto ; Maluquer, Clara...
Reproducció del document publicat a: https://doi.org/10.1002/cnr2.1358.  , 2021
 
1-15